0001209191-23-047348.txt : 20230825 0001209191-23-047348.hdr.sgml : 20230825 20230825164544 ACCESSION NUMBER: 0001209191-23-047348 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230824 FILED AS OF DATE: 20230825 DATE AS OF CHANGE: 20230825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Palmer Pamela P CENTRAL INDEX KEY: 0001511365 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 231209006 MAIL ADDRESS: STREET 1: C/O ACELRX PHARMACEUTICALS, INC. STREET 2: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1850 GATEWAY DRIVE STREET 2: SUITE 175 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 1850 GATEWAY DRIVE STREET 2: SUITE 175 CITY: SAN MATEO STATE: CA ZIP: 94404 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-24 0 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001511365 Palmer Pamela P C/O ACELRX PHARMACEUTICALS, INC. 1850 GATEWAY DRIVE, SUITE 175 SAN MATEO CA 94404 1 1 0 0 Chief Medical Officer 0 Common Stock 2023-08-24 4 S 0 9514 1.17 D 38195 D Common Stock 2023-08-25 4 S 0 7442 1.089 D 30753 D The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.17 to $1.19 on August 24, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares sold at each separate price. Balance includes non-reportable acquisition of 4,394 shares of Common Stock through the Company's Employee Stock Purchase Plan on February 28, 2023. /s/ Martha Adler. Attorney-In-Fact 2023-08-25